Videos
Videos
Advertisement
Laura LitwinConferences | February 21, 2025
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
View More
Krystal Waldrup, BSN, RN, OCNConferences | February 14, 2025
Krystal Waldrup, BSN, RN, OCN, shares how the training improved nurse confidence and opened up capacity in the oncology unit.
Anna Barata, PhDHematology & Blood Cancer | February 14, 2025
Anna Barata, PhD, shares key insights from the CAR-T research that she presented during the 2025 Tandem Meetings.
Krystal Waldrup, BSN, RN, OCNConferences | February 13, 2025
The Tandem Transplantation and Cellular Therapy Meetings offer a dedicated nursing track, networking opportunities, and more.
Chelsea Honstain, NPConferences | February 12, 2025
Chelsea Honstain, NP, is vice chair of the APP Steering Committee and chair of the Education Subcommittee.
Anna Barata, PhDConferences | February 12, 2025
The Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR are taking place February 12-15.
Martha Raymond, MAGI Cancer | February 6, 2025
Martha Raymond, MA, founder of the GI Cancers Alliance, shares insights from her recent presentation on the programming.
Prithviraj Bose, MDMPN | January 7, 2025
Prithviraj Bose, MD, unpacks key highlights in MPN treatment and research at ASH 2024.
Amy Pierre, RN, BSN, ANP-BCMultiple Myeloma | December 31, 2024
Amy Pierre, RN, BSN, ANP-BC, explains why it's important for advanced practice nurses to be invovled in research.
Lisa Hwa, APRN, CNP, DNP, MSProfessional Development | December 27, 2024
Lisa Hwa, APRN, CNP, DNP, MS, is a member of the ASH Medical Educators Institute and has presented multiple ASH abstracts.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOMultiple Myeloma | December 20, 2024
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, shares her hopes for the new year.
Cecilia BrownConferences | December 20, 2024
Pierluigi Porcu, MD, discusses the phase II Tellomak trial and how nurses can help patients manage this rare disease.
Amy Pierre, RN, BSN, ANP-BCConferences | December 20, 2024
Amy Pierre, RN, BSN, ANP-BC, reflects on highlights from ASH 2024 and why it's critical for advanced practitioners to attend.
Kirk R. Schultz, MD, FCAHSConferences | December 20, 2024
An expert in pediatric GVHD shares his hopes and projections for the future of GVHD treatment and research.
Samantha Shenoy, NPConferences | December 20, 2024
Samantha Shenoy, NP, shares why it's important for nurses and APPs to consider attending the annual meeting.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPOConferences | December 19, 2024
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses the significance of ASH 2024.
Ellinor Goergen, MDConferences | December 19, 2024
The CLL12 trial included patients with treatment-naive, asymptomatic, early-stage chronic lymphocytic leukemia.
Lisa Hwa, APRN, CNP, DNP, MSConferences | December 18, 2024
Lisa Hwa, APRN, CNP, DNP, MS, discusses her work with the ASH Medical Educators Institute and her conference experience.
Amy Pierre, RN, BSN, ANP-BCConferences | December 18, 2024
Amy Pierre, RN, BSN, ANP-BC, shares insights and key action items from her ASH 2024 presentation on the topic.
Richard Newcomb, MDConferences | December 17, 2024
Richard Newcomb, MD, shares insights from his ASH 2024 presentation and explains why nurses play a major role in outcomes.
Advertisement
Advertisement
Advertisement